Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escalation Study of BTP-114 in Patients With Advanced Solid Tumors and BRCA or DNA Repair Mutation

NCT02950064 is registered in ClinicalTrials.gov with Placon Therapeutics as lead sponsor.

NCT NCT02950064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02950064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escalation Study of BTP-114 in Patients With Advanced Solid Tumors and BRCA or DNA Repair Mutation
Lead sponsor
Placon Therapeutics
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2016
Completion date
August 31, 2020
Enrollment
95 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, ovarian neoplasms, pancreatic neoplasms, prostatic neoplasms